GLP-1 agonists (Byetta, etc) are a good choice for weight loss in patients WITHOUT diabetes.

This isn’t completely true. GLP-1 agonists do result in short-term weight loss, but safety is a concern.

Alternative weight loss meds are tempting in light of all the cardiovascular and other concerns with antiobesity drugs.

GLP-1 agonists seem to cause weight loss by slowing gastric motility, increasing satiety, and suppressing appetite.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote